Marta Gómez Quintanilla

Spanish Representative – Health & IMI - H2020

CDTI – Ministry of Economy, and Competitiveness marta.gomez[at]cdti.es

http://bit.ly/1nj1ToZ

@EsHorizonte2020

HORIZON 2020:HEALTH, DEMOGRAPHIC CHANGE & WELLBEING

Trends and Strategies in Health

Madrid, 8th Nov. 2017

* Acudan a las webs oficiales para disponer de la información más actualizada

3

Oportunities

Looking at the future

Final recommendations

4

Oportunities

Looking at the future

Final recommendations

5

The EU Framework Programme for Research and Innovation

Essential part of European Strategy: Europe 2020

Focus on societal challengese.g. Health

77.028 M€

Simplification

Partnerships: Public-Private, Public-Public

International cooperation

2014-2020

6

Budget (M€)

7

Health, Demographic change and Well-being

Objectives:

• Improve health and well-being outcomes,

• promote healthy and active ageing,

• promote market growth, job creation, and the EU as a global leader in the health area.

Better health for all

8

Implementation

«Ordinary»calls

Partnerships with:- MMEE y AACC- Industry- Other

• Work programme(WP)• Implemented by EC (or its ejecutive agencies)

• Partnerships• Public-Private(PPP/JTI)• Public-Public(P2P)•Other: ERANET, ...

He

alth

, De

mo

grap

hic

ch

ange

an

d W

ell-

be

ing

(7.2

57

)

9

• Strategic focus → Europe 2020, Innovation Union, Digital Single

Market…

Work Programmes characteristics

FOCUS ON THE IMPACT

10

Commission to invest €30 billion in new solutions for societal challenges and breakthrough innovation -> WP 2018-2020

EU R&I funding programme Horizon 2020 during 2018-2020, including €2.7 billion to kick-start a European Innovation Council (EIC)

Focusing on political priorities :• A low-carbon, climate resilient future: €3.3 billion• Circular Economy: €1 billion• Digitising and transforming European industry and

services: €1.7 billion• Security Union: €1 billion• Migration: €200 million€2.2 billion will be earmarked for clean energy

11

Commission to invest €30 billion in new solutions for societal challenges and breakthrough innovation• Boosting 'blue sky' research

• Enhancing international cooperation

• Spreading excellence

• Simplifying rules of participation further -> lump-sum

pilot, a new, simpler approach to providing financial

support to participants. It will shift the focus of ex-ante

controls from financial checks to the scientific-technical content of the projects -> SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)

• Open Science

13

WP 2018-2020: Europe is facing 4 mainhealthcare challenges

The rising and potentially

unsustainable health and care costs

The risk to lose our ability to protect the populations

against the threats of infectious diseases

Health inequalities and access to health

and care

Growing influence on health of external

environmental factors including climate change

14

Consider specific research priorities

15

…and related research priorities

16

DG SANTÉ – PUBLIC HEALTH – All policieshttp://ec.europa.eu/health/index_en.htm

17

WP Health: 2018 calls OPEN, 2019 calls described, 2020 only titleshttps://ec.europa.eu/research/participants/portal/desktop/en/home.html

http://ec.europa.eu/research/participants/d

ata/ref/h2020/wp/2018-2020/main/h2020-

wp1820-health_en.pdf

18

SUPPORT: helpdesk y guidelines

IPRs • IPR Helpdesk: Assistance on Intellectual Property issues www.iprhelpdesk.eu

Ethics• Ethics: from proposal definition to project implementation http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm

• Guidance How to complete your ethics self-assessment http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/ethics/h2020_hi_ethics-self-assess_en.pdf

ClinicalStudies

• Template for essential information to be provided for proposals including clinical trials / studies / investigations http://ec.europa.eu/research/participants/data/ref/h2020/other/legal/templ/h2020_tmpl-clinical-studies_2018-2020_en.pdf

Sex & Gender

• Guidance on methods of sex/gender analysis and the issues to be taken into account http://ec.europa.eu/research/science-society/gendered-innovations/index_en.cfm

• Fact sheet: Gender Equality in Horizon 2020https://ec.europa.eu/programmes/horizon2020/sites/horizon2020/files/FactSheet_Gender_091213_final.pdf

H2020• Horizon 2020 Helpdesk http://ec.europa.eu/research/index.cfm?pg=enquiries

• H2020 manual https://ec.europa.eu/research/participants/portal/desktop/en/funding/guide.html

• Guideline: http://ec.europa.eu/research/participants/data/ref/h2020/other/gm/h2020-guide-comm_en.pdf

• Open acces: http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/open-access-data-

management/open-access_en.htm

Comunication

Dissemination

19

• Multi-disciplinar

• Multi-sectorial

• Multi-stakeholder

• Other aspects tbc: gender, etc.

Team work: build a network

20

Implementation

Partnerships with:- MMEE y AACC- Industry- Other

• Partnerships• Public-Private(PPP/JTI)• Public-Public(P2P)•Other: ERANET, ...

He

alth

, De

mo

grap

hic

ch

ange

an

d W

ell-

be

ing

(7.2

57

)

26

Scenario

EDCTP2683 M€

IMI21.638 M€

AAL175 M€

ICTs for Health¿1.400 M€?

Health, Demographic

Change & Wellbeing7.257 M€

EIPAHA

0 M€

JPIHDHL

¿? M€

JPIAMR

¿? M€

JPIJPND

¿? M€

JPIMYBL

¿? M€

FET

HBP¿? M€

EMPIR60 M€(300M€ total)

Societal Challenge 1: Initiatives running with

its budget & relatedinitiatives

• AAL: Active & Assisted Living

• HBP: Human Brain Project

• IDFF: Infectious Diseases Finance Facility

• IMI: Innovative Medicines Initiative

• JPI: Joint Programming Initiative

• JPI HD&HL: A Healthy diet for a healthy life

• JPND: Joint Programming in Neurodegenerative Research

• JPI MYBL: Joint Programming More Years, Better Lives

• JPI AMR: Joint Programming in Antimicrobial Resistance

• PMI: Personalised Medicine Initiative

• EHBMI: European Human Biomonitoring Initiative

• FET: Future and Emerging Technologies

• EDCTP: The European and Developing Countries Clinical Trials Partnership

• EIP AHA: European Innovation Partnership on Active and Healthy Ageing

• EMPIR: European Metrology Programme for Innovation and Research

• KIC HL&AA: Knowledge and Innovation Communities on Healthy Living and Active Ageing

•vv

EHBMI50 M€

IDFF100 M€

++

PMI

Eurostars287 M€

EITHEALTH

¿? M€

27

Scenario

ICTs for Health¿1.400 M€?

Health, Demographic

Change & Wellbeing7.257 M€

WP Calls

≈ 50% of SC1 budget is spend through WorkProgrammes

• AAL: Active & Assisted Living

• EDCTP: The European and Developing Countries Clinical Trials Partnership

• EHBMI: European Human Biomonitoring Initiative

• EIP AHA: European Innovation Partnership on Active and Healthy Ageing

• EMPIR: European Metrology Programme for Innovation and Research

• FET: Future and Emerging Technologies

• HBP: Human Brain Project

• IDFF: Infectious Diseases Finance Facility

• IMI: Innovative Medicines Initiative

• JPI: Joint Programming Initiative

• JPI HD&HL: A Healthy diet for a healthy life

• JPND: Joint Programming in Neurodegenerative Research

• JPI MYBL: Joint Programming More Years, Better Lives

• JPI AMR: Joint Programming in Antimicrobial Resistance

• KIC HL&AA: Knowledge and Innovation Communities on Healthy Living and Active Ageing

• PMI: Personalised Medicine Initiative

•

28

Oportunities

Looking at the future

Final recommendations

29

Future FP (FP9? IMI3?) – Trends

https://ec.europa.eu/research/evaluations/pd

f/brochure_interim_evaluation_horizon_2020

_key_findings.pdf

https://publications.europa.eu/en/publication-

detail/-/publication/b2d78a84-3aae-11e7-

a08e-01aa75ed71a1/language-en

http://ec.europa.eu/research/evaluations/pdf/arc

hive/other_reports_studies_and_documents/hlg

_2017_report.pdf

“Lamy Report”High Level Group on maximising impact of EU

Research and Innovation Programmes

htt

ps:/

/ec.e

uro

pa.e

u/r

ese

arc

h/e

va

lua

tio

ns/p

df/

b

oo

k_

inte

rim

_e

va

lua

tio

n_h

orizo

n_

202

0.p

df

A report from project BOHEMIABeyond the Horizon: Foresight in Support of

the Preparation of the European Union’s Future Policies in Research and Innovation

30

Moedas & others inspiration

Evolution notrevolution

Mission-driven R&I

Increase in budget

• Supporting the very best new science

• Simplest and mostuser-friendly

• Bring research and innovation together

• Capture the publicimagination

• Interdisciplinary, inter-sectoral and international

• Go beyond what is currently possible

31

Oportunities

Looking at the future

Final recommendations

32

FACTS:

Horizon 2020 has clear objetives, whichare different to previous programmes(e.g. 7th Framework Programme)-> Policyimplementation

The environment has changed and it isin constant evolution → towards thenext Framework Programme (FP9?)

“It is not the strongest of the speciesthat survives, nor the most intelligent, but the most responsive to change” Charles Darwin

StrategiesPolíciesTrends

….

In Health, we lovepilots!

Invest to be ready!

33

Final recommendations

Be ready

Be active

Get support

34

CDTI support in Health. Who? What?

Work Programmesdefinition

Strategic orientation,Future initiatives

Proposalspreparation

Projectsfollow-up

Marta Gómez Quintanilla

(Representante)marta.gomez@cdti.es

Carolina Carrasco (NCP- Punto Nacional de Contacto)carolina.carrasco@cdti.es

Marta de Diego(Experta IMI)marta.dediego@cdti.es

915815562

35

Opportunity rarely knocks on your door. Knock rather on opportunity's door if

you ardently wish to enter.

B. C. Forbes

Bertie Charles Forbes (May 14, 1880 – May 6, 1954) was a Scottish financial journalist and author who founded Forbes Magazine.

36

NCP = facilitatorhttp://eshorizonte2020.es/que-es-horizonte-2020/horizonte-2020-en-espana/puntos-nacionales-de-contacto

Carolina Carrasco (CDTI) - carolina.carrasco@cdti.es

Juan Riese (ISCIII) - jriese@eu-isciii.esNCPs SALUD

NCP

37

H2020: Web, guía y twitter españoles

www.eshorizonte2020.es

@EsHorizonte2020

www.guiah2020.es

38

CONTACTO:

Marta Gómez Quintanilla

Spanish Representative - HEALTH

Spanish Representative - IMI

Spanish MB Member - JPND

34 91 581 55 62 / 00

marta.gomez[at]cdti.es - www.cdti.es

http://bit.ly/1nj1ToZ

@EsHorizonte2020

@EU_RDI_LifeSci

39

Portal del participantehttp://ec.europa.eu/research/participants/portal/desktop/en/home.html

40

Apoyo CDTI en todas las fases

• APCs: ayuda a la preparación de propuestas comunitarias (empresas) http://bit.ly/1i2DsHv

• Programa de Especialización de Gestores: estancias de gestores en nuestra oficina SOST – Programa formación + plan de trabajo en Bruselas http://bit.ly/1iuOHHQ

• Oficinas apoyo: contratación de servicios a entidades especializadas en el apoyo a empresas para su participación en el Horizonte 2020 http://bit.ly/1g1vzOn

• Red PIDI: Servicio de Información y Asesoramiento Telemático de la Red de Puntos de Información sobre Actividades de Investigación, Desarrollo e Innovación (PI+D+i) → nodo especializado en programas internacionales para la financiación de proyectos de I+D. http://bit.ly/1gh3w1B

41

¿Donde hay más información?

https://webgate.ec.europa.eu/eipaha

http://ec.europa.eu/research/horizon2020/index_en.cfm http://ec.europa.eu/research/health/index_en.html

http://ec.europa.eu/digital-agenda/en/eHealth%20http://ec.europa.eu/dgs/health_consumer/index_en.htm http://ec.europa.eu/health/index_en.htm

http://ec.europa.eu/europe2020/index_es.htm http://ec.europa.eu/research/innovation-union/index_en.cfm

http://www.eshorizonte2020.es/

www.iprhelpdesk.eu

http://ec.europa.eu/research/participants/portal

www.imi.europa.eu

42

GLOSSARY & LINKS• AAL: Ambient Assisted Living www.aal-europe.eu /Active and Assisted Living

• COCIR: European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry www.cocir.org

• EC: European Commission http://ec.europa.eu

• EDCTP: The European and Developing Countries Clinical Trials Partnership www.edctp.org

• EJP: European Joint Programme http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/other/index.html

• EFPIA: The European Federation of Pharmaceutical Industries and Associations www.efpia.eu

• EIP: European Innovation Partnership http://ec.europa.eu/research/innovation-union/index_en.cfm?pg=eip

• EIT: European Institute of Innovation & Technology http://eit.europa.eu

• EMPIR: European Metrology Programme for Innovation and Research www.emrponline.eu

• FET: Future and Emerging Technologies

• HBP: Human Brain Project www.humanbrainproject.eu

• IMI: Innovative Medicines Initiative www.imi.europa.eu

• JPI AMR: Joint Programming in Antimicrobial Resistance www.jpiamr.eu

• JPI HD&HL: A Healthy diet for a healthy life www.healthydietforhealthylife.eu

• JPI MYBL: Joint Programming More Years, Better Lives www.jp-demographic.eu

• JPI: Joint Programming Initiative http://ec.europa.eu/research/era/areas/programming/joint_programming_en.htm

• JPND: Joint Programming in Neurodegenerative Research www.neurodegenerationresearch.eu

• KIC: Knowledge and Innovation Community http://eit.europa.eu/kics / HL&AA: Healthy Living and Active Ageing

• PPP: Public-Private Partnership & P2P: Public-Public Partnership http://ec.europa.eu/research/era/partnership/partnering_en.htm

• SBIR: Small Business Innovation Research www.sbir.gov

• SIA: Strategic Implementation Agenda / SIP: Strategic Implementation Plan

• SME: Small and medium-sized enterprises http://ec.europa.eu/enterprise/policies/sme/index_en.htm